Allworth Financial’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Buy |
3,825
+1,627
| +74% | +$44.9K | ﹤0.01% | 1508 |
|
|
2025
Q1 | $60.2K | Buy |
2,198
+297
| +16% | +$8.14K | ﹤0.01% | 1461 |
|
|
2024
Q4 | $73.2K | Buy |
1,901
+281
| +17% | +$10.8K | ﹤0.01% | 1395 |
|
|
2024
Q3 | $108K | Sell |
1,620
-213
| -12% | -$14.2K | ﹤0.01% | 1048 |
|
|
2024
Q2 | $222K | Buy |
1,833
+122
| +7% | +$14.8K | ﹤0.01% | 783 |
|
|
2024
Q1 | $182K | Buy |
1,711
+51
| +3% | +$5.44K | ﹤0.01% | 815 |
|
|
2023
Q4 | $165K | Buy |
1,660
+101
| +6% | +$10K | ﹤0.01% | 777 |
|
|
2023
Q3 | $161K | Buy |
1,559
+49
| +3% | +$5.06K | ﹤0.01% | 742 |
|
|
2023
Q2 | $183K | Sell |
1,510
-322
| -18% | -$39.1K | ﹤0.01% | 724 |
|
|
2023
Q1 | $281K | Sell |
1,832
-162
| -8% | -$24.9K | ﹤0.01% | 581 |
|
|
2022
Q4 | $358K | Buy |
1,994
+542
| +37% | +$97.4K | ﹤0.01% | 528 |
|
|
2022
Q3 | $172K | Sell |
1,452
-328
| -18% | -$38.9K | ﹤0.01% | 625 |
|
|
2022
Q2 | $254K | Buy |
1,780
+60
| +3% | +$8.56K | ﹤0.01% | 518 |
|
|
2022
Q1 | $296K | Buy |
1,720
+515
| +43% | +$88.6K | ﹤0.01% | 475 |
|
|
2021
Q4 | $306K | Sell |
1,205
-187
| -13% | -$47.5K | ﹤0.01% | 448 |
|
|
2021
Q3 | $536K | Buy |
1,392
+96
| +7% | +$37K | 0.01% | 320 |
|
|
2021
Q2 | $305K | Sell |
1,296
-371
| -22% | -$87.3K | 0.01% | 316 |
|
|
2021
Q1 | $218K | Buy |
1,667
+85
| +5% | +$11.1K | ﹤0.01% | 342 |
|
|
2020
Q4 | $165K | Buy |
1,582
+952
| +151% | +$99.3K | ﹤0.01% | 302 |
|
|
2020
Q3 | $45K | Buy |
630
+40
| +7% | +$2.86K | ﹤0.01% | 437 |
|
|
2020
Q2 | $38K | Buy |
590
+40
| +7% | +$2.58K | ﹤0.01% | 466 |
|
|
2020
Q1 | $16K | Buy |
+550
| New | +$16K | ﹤0.01% | 602 |
|